These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1669520)

  • 1. Issues in the early termination of the aspirin component of the Physicians' Health Study. Data Monitoring Board of the Physicians' Health Study.
    Cairns J; Cohen L; Colton T; DeMets DL; Deykin D; Friedman L; Greenwald P; Hutchison GB; Rosner B
    Ann Epidemiol; 1991 Aug; 1(5):395-405. PubMed ID: 1669520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers of compliance in the Physicians' Health Study.
    Satterfield S; Greco PJ; Goldhaber SZ; Stampfer MJ; Swartz SL; Stein EA; Kaplan L; Hennekens CH
    Am J Prev Med; 1990; 6(5):290-4. PubMed ID: 2268456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline characteristics of participants in the Physicians' Health Study: a randomized trial of aspirin and beta-carotene in U.S. physicians.
    Manson JE; Buring JE; Satterfield S; Hennekens CH
    Am J Prev Med; 1991; 7(3):150-4. PubMed ID: 1931143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine and subsequent risk of stroke in the Physicians' Health Study.
    Buring JE; Hebert P; Romero J; Kittross A; Cook N; Manson J; Peto R; Hennekens C
    Arch Neurol; 1995 Feb; 52(2):129-34. PubMed ID: 7848119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of aspirin and beta-carotene among U.S. physicians.
    Hennekens CH; Eberlein K
    Prev Med; 1985 Mar; 14(2):165-8. PubMed ID: 3900975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study.
    Steering Committee of the Physicians' Health Study Research Group
    N Engl J Med; 1988 Jan; 318(4):262-4. PubMed ID: 3275899
    [No Abstract]   [Full Text] [Related]  

  • 7. Final report on the aspirin component of the ongoing Physicians' Health Study.
    Steering Committee of the Physicians' Health Study Research Group
    N Engl J Med; 1989 Jul; 321(3):129-35. PubMed ID: 2664509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians.
    Christen WG; Glynn RJ; Ajani UA; Schaumberg DA; Chew EY; Buring JE; Manson JE; Hennekens CH
    Arch Ophthalmol; 2001 Aug; 119(8):1143-9. PubMed ID: 11483080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.
    Hennekens CH; Buring JE; Manson JE; Stampfer M; Rosner B; Cook NR; Belanger C; LaMotte F; Gaziano JM; Ridker PM; Willett W; Peto R
    N Engl J Med; 1996 May; 334(18):1145-9. PubMed ID: 8602179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the effect of the run-in on the power of the Physicians' Health Study.
    Lang JM; Buring JE; Rosner B; Cook N; Hennekens CH
    Stat Med; 1991 Oct; 10(10):1585-93. PubMed ID: 1947514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost and efficiency in clinical trials: the U.S. Physicians' Health Study.
    Buring JE; Hennekens CH
    Stat Med; 1990; 9(1-2):29-33. PubMed ID: 2345836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study.
    Glynn RJ; Buring JE; Manson JE; LaMotte F; Hennekens CH
    Arch Intern Med; 1994 Dec 12-26; 154(23):2649-57. PubMed ID: 7993148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.
    Ridker PM; Manson JE; Gaziano JM; Buring JE; Hennekens CH
    Ann Intern Med; 1991 May; 114(10):835-9. PubMed ID: 2014943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians.
    Stampfer MJ; Buring JE; Willett W; Rosner B; Eberlein K; Hennekens CH
    Stat Med; 1985; 4(2):111-6. PubMed ID: 4023472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study.
    Lee IM; Cook NR; Manson JE; Buring JE; Hennekens CH
    J Natl Cancer Inst; 1999 Dec; 91(24):2102-6. PubMed ID: 10601381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).
    Cook NR; Le IM; Manson JE; Buring JE; Hennekens CH
    Cancer Causes Control; 2000 Aug; 11(7):617-26. PubMed ID: 10977106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study.
    Cook NR; Cole SR; Hennekens CH
    Am J Epidemiol; 2002 Jun; 155(11):1045-53. PubMed ID: 12034583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-selected posttrial aspirin use and subsequent cardiovascular disease and mortality in the physicians' health study.
    Cook NR; Hebert PR; Manson JE; Buring JE; Hennekens CH
    Arch Intern Med; 2000 Apr; 160(7):921-8. PubMed ID: 10761956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I.
    Christen WG; Ajani UA; Schaumberg DA; Glynn RJ; Manson JE; Hennekens CH
    Arch Ophthalmol; 2001 Mar; 119(3):405-12. PubMed ID: 11231774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on aspirin in the primary prevention of cardiovascular disease.
    Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
    Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.